Profile

Mercedes Porosnicu, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

52 Ratings
8 Comments

Mercedes Porosnicu, M.D.

Assistant Professor,


Clinical Interests

Head and Neck Cancers, Head and Neck Oncology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-8664

Insurance Accepted »

Additional Languages

French, Romanian

Education & Training

  • M.D., Inst Medicine Lasi-Romania, 1987
  • Residency, Suny-Buffalo Affil Hosps, 1998
  • Fellowship, Hematology And Oncology, University of Miami, 2001
  • Fellowship, University of Miami, 2002
  • Fellowship, University of Miami, 2003

Memberships

  • Am Assn Of Cancer Research
  • Am Soc of Clinical Oncology

NPI Number

  • 1417903584
Mercedes Porosnicu, M.D.

Doctor Rating

4.7 out of 5

52 Ratings
8 Comments

Mercedes Porosnicu, M.D.

Assistant Professor, Hematology & Oncology
Comprehensive Cancer Center
Translational Science Institute

Research Interests

cancer/oncogenesis

Contact Information

Academic: 336-713-4392 | Department: 336-716-8664

Recent Publications

Garg S, Kilburn JM, Lucas JT Jr, Randolph D, Urbanic JJ, Hinson WH, Kearns WT, Porosnicu M, Greven K. Reirradiation for second primary or recurrent cancers of the head and neck: dosimetric and outcome analysis. Head Neck. 2015;():.

Westcott MM, Liu J, Rajani K, D'Agostino R Jr, Lyles DS, Porosnicu M. Interferon beta and interferon alpha 2a differentially protect head and neck cancer cells from vesicular stomatitis virus-induced oncolysis. J Virol. 2015;89(15):7944-7954.

Bansal N, Mims J, Kuremsky JG, Olex AL, Zhao W, Yin L, Wani R, Qian J, Center B, Marrs GS, Porosnicu M, Fetrow JS, Tsang AW, Furdui CM. Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer. Antioxid Redox Signal. 2014;21(2):221-236.

Vatca M, Lucas JT Jr, Laudadio J, D'Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, Porosnicu M. Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Oral Oncol. 2014;50(9):869-876.

Lucas JT, Porosnicu M, Plasser R, Sullivan CA, Waltonen JD, Brown JD, Greven KM. Phase 1/2 clinical trial of re-irradiation with pemetrexed and erlotinib followed by maintenance erlotinib for recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN) [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S179.

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Porosnicu M, Liu J, Lyles D. Susceptibility of head and neck cancer to an attenuated model of the oncolytic vesicular stomatitis virus expressing suicide genes [abstract]. J Clin Oncol. 2010;27(15 Suppl):e14604.

Blackstock A, Petty J, Oaks T, Porosnicu M, Clark H, Lovato J, Miller A. Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. J Clin Oncol. 2007;25(18 Suppl):Abstr18165.

Blackstock AW, Jensen CA, Petty WJ, Oaks T, Porosnicu M, Clark H, Lovato JF, Miller A. Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S476.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Hematology & Oncology

Clinical Interests

Head and Neck Cancers, Head and Neck Oncology
Mercedes Porosnicu, M.D.

Mercedes Porosnicu, M.D.

Assistant Professor, Hematology & Oncology
Comprehensive Cancer Center
Translational Science Institute

Doctor Rating

4.7 out of 5

Mercedes Porosnicu, M.D.52 Ratings
8 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.8
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/30/2015

Everyone has been helpful to answer questions and help us go through the treatments.

4/3/2015

The best experience.

4/1/2015

Everyone was excellent & caring.

3/17/2015

*Dr. P helped save my life so I love her and her staff. Amen!

12/30/2014

Gave me the good news that cancer had not returned!

12/17/2014

They really care that I understand everything and are concerned about me as a person.

10/28/2014

Dr. P is thr best. She is both straight forward and compassionate

9/2/2014

Very good.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.